Treatment of Group B Streptococcus Urinary Tract Infection
For Group B Streptococcus (GBS) urinary tract infections, penicillin G or ampicillin should be used as first-line therapy, with penicillin G being preferred due to its narrower spectrum of activity and lower likelihood of selecting for resistant organisms. 1
First-Line Treatment Options
Preferred Agents:
- Penicillin G: 5 million units IV initially, then 2.5-3.0 million units IV every 4 hours 1, 2
- Ampicillin: 2 g IV initially, then 1 g IV every 4 hours 1
Treatment Duration:
- Uncomplicated UTI: 7-10 days
- Complicated UTI or pyelonephritis: 10-14 days
- Continue treatment for at least 48-72 hours after symptom resolution 1
Alternative Options for Penicillin-Allergic Patients
For patients with non-severe penicillin allergy:
- Cefazolin: 2 g IV initial dose, then 1 g IV every 8 hours 1
For patients with high risk of anaphylaxis:
- Clindamycin: 900 mg IV every 8 hours (only if susceptibility testing confirms sensitivity) 1, 2
- Vancomycin: 1 g IV every 12 hours (for clindamycin-resistant strains) 1, 3
For uncomplicated lower UTIs:
Antibiotic Resistance Considerations
All GBS isolates remain susceptible to penicillin, ampicillin, cefazolin, and vancomycin 5. However, resistance to alternative agents is increasing:
- Clindamycin resistance: Increased from 10.5% to 15.0% 5
- Erythromycin resistance: Increased from 15.8% to 32.8% 5
Therefore, susceptibility testing is essential when using non-beta-lactam antibiotics, particularly for penicillin-allergic patients 1.
Special Considerations
Pregnant Patients
- Any amount of GBS in urine during pregnancy indicates heavy colonization
- Requires both immediate treatment of the current infection and intrapartum prophylaxis during labor 1
- Obtain urine culture after completion of treatment to confirm eradication 1
- Intrapartum prophylaxis is required regardless of whether the patient received treatment earlier in pregnancy 1
Antibiotic Selection Rationale
Penicillin G is preferred over ampicillin because:
- It has a narrower spectrum of antimicrobial activity
- Less likely to select for resistant organisms 6
- Both achieve adequate levels in the fetal circulation and amniotic fluid 2
Follow-up
- Obtain a urine culture after completion of treatment to confirm eradication of the infection 1
- For pregnant women, intrapartum prophylaxis is still required even if the UTI was successfully treated earlier in pregnancy 1
Common Pitfalls to Avoid
- Failing to perform susceptibility testing for penicillin-allergic patients
- Using erythromycin without susceptibility testing due to high resistance rates
- Not obtaining follow-up cultures to confirm eradication
- Forgetting intrapartum prophylaxis for pregnant women with history of GBS bacteriuria
- Using fluoroquinolones as first-line therapy when better alternatives exist 1
By following these evidence-based recommendations, clinicians can effectively treat GBS UTIs while minimizing the risk of treatment failure and antibiotic resistance.